International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors
about
sameAs
IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channelsCalcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraineAllostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapesCrystal structure of the human receptor activity-modifying protein 1 extracellular domainCalcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cellsModulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cellsMicroglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In VivoMechanisms of islet amyloidosis toxicity in type 2 diabetesStructure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptorsOn the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP PeptidesRole of Cholesterol and Phospholipids in Amylin Misfolding, Aggregation and Etiology of Islet AmyloidosisIntermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexesRamping it up: RAMP1 and the implications for migraineReceptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of ReceptorsFunctions of the cytoplasmic tails of the human receptor activity-modifying protein components of calcitonin gene-related peptide and adrenomedullin receptorsAmylin receptor blockade stimulates food intake in ratsThe expanding repertoire of receptor activity modifying protein (RAMP) functionDissection of functional residues in receptor activity-modifying proteins through phylogenetic and statistical analysesAmyloid β (Aβ) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathwaysThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsThe vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.Solution state structures of human pancreatic amylin and pramlintide.Calcitonin gene-related peptide receptor antagonists for the treatment of migraine: a patent review.Activation of calcitonin receptor and calcitonin receptor-like receptor by membrane-anchored ligands.Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats.Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin.The hector G-protein coupled receptor is required in a subset of fruitless neurons for male courtship behavior.Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primatesRole of Ser102 and Ser104 as regulators of cGMP hydrolysis by PDE5ABacterial expression and purification of a heterodimeric adrenomedullin receptor extracellular domain complex using DsbC-assisted disulfide shuffling.Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesisAmylin receptor signaling in the nucleus accumbens negatively modulates μ-opioid-driven feeding.Role in diuresis of a calcitonin receptor (GPRCAL1) expressed in a distal-proximal gradient in renal organs of the mosquito Aedes aegypti (L.).An angiogenic role for adrenomedullin in choroidal neovascularization.Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction.Neuronal receptor activity-modifying protein 1 promotes energy expenditure in mice.Evolution of a potential hormone antagonist following gene splicing during primate evolution.Actions of β-amyloid protein on human neurons are expressed through the amylin receptor.Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment.Structural similarities and differences between amyloidogenic and non-amyloidogenic islet amyloid polypeptide (IAPP) sequences and implications for the dual physiological and pathological activities of these peptides.
P2860
Q24259024-AB19229B-91C4-47F2-B05C-F30521460D40Q24632671-5F12FB1E-C843-4489-840D-77A0ED4524FFQ24633877-AEC90E5A-C7CE-49E9-BB18-A93EFF90A760Q24644526-2D6375D7-1DFB-4A47-9C17-1DA0572BAF9BQ24652416-A3043B5B-F243-460C-AFC6-F5A3E04F8436Q24672543-69E5EB71-8331-4983-A5EC-23033FC86647Q26798185-51271930-94F8-4E34-88CD-62F49B4E4A55Q26823708-ABC13E43-6A48-4CA5-AE32-CBA16C40DA3FQ26851381-8A2A791A-E1D2-4317-8CBD-9DAC7C00AEC0Q27022467-6BA77738-679B-4828-B703-26CA8B2E0A04Q28088416-F51DF3FE-AB1C-4A58-A349-3B1845287382Q28184238-FC6FD694-ED6B-431C-ACB5-334D4ECF73F9Q28266882-5E60D52A-7248-47F2-8211-9828CC6AD03CQ28278110-EEC083B7-EFB3-492C-A61A-FD3FC7F5A708Q28291519-CF0A45BB-2901-4186-89DC-2319D4F858C9Q28578065-47EFB6D1-3988-4D7D-8F37-0B977D5E8016Q28601134-3BD760A2-4949-4157-88E9-5325E128B5FEQ28762015-A5C73E19-7213-47A7-B148-8962E6721D35Q30175699-CFD7F26D-98F3-40CE-8A42-BABCCCF2E283Q30486707-1CC6122D-D09F-4A95-B27B-F8658D2CCBB2Q33254441-277FA337-DAD6-4E42-999A-3B702E5AF128Q33481542-B54F8AEF-2720-4CBF-884E-6D46C9EC533BQ33516651-744836BA-24DE-459F-BCAE-D7A080EFC611Q33569613-D68BEFFB-60DA-40A1-9484-FEBD743DEE71Q33692151-B6984785-D818-44AD-9482-D7E9D5E19F91Q33895725-5582372B-165A-45E2-9137-A2C2FB0F4869Q34091427-7C74044A-E3F9-4E86-A84C-39C643B628E8Q34150227-022E5BA7-6DA6-499B-A92C-1973E8A7BB54Q34231776-249B64F9-5416-4DF6-AF05-F74CB0F24901Q34318205-C3A8AFE3-89C8-4275-991C-776995C07535Q34478940-993CBAFE-343C-4222-915B-00F4726014F5Q34499302-0F065798-1239-4D2F-9749-933EE8A4E0DDQ34500221-58FC89D6-85BD-4294-9FC1-CEE2ACD4B407Q34631730-2C08FA96-9B3E-4F08-BB8B-48489C8A1478Q34712005-9505F231-4D2C-498E-A499-13A395030EA5Q34718618-4E61FDB1-00E7-4A29-80E3-7CD645DAB72EQ34749669-6B6C329B-8EF3-4146-825B-E9636BF11EF1Q34760866-915595BC-F780-4591-BA34-C9021F4E3DECQ34978115-1DA16BC0-8A37-4B0E-8B2F-6665F2D7A305Q34979345-401A13D3-7779-4E14-AE3E-205BFD12F597
P2860
International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
International Union of Pharmac ...... ylin, and calcitonin receptors
@ast
International Union of Pharmac ...... ylin, and calcitonin receptors
@en
International Union of Pharmac ...... ylin, and calcitonin receptors
@nl
type
label
International Union of Pharmac ...... ylin, and calcitonin receptors
@ast
International Union of Pharmac ...... ylin, and calcitonin receptors
@en
International Union of Pharmac ...... ylin, and calcitonin receptors
@nl
prefLabel
International Union of Pharmac ...... ylin, and calcitonin receptors
@ast
International Union of Pharmac ...... ylin, and calcitonin receptors
@en
International Union of Pharmac ...... ylin, and calcitonin receptors
@nl
P2093
P921
P3181
P356
P1476
International Union of Pharmac ...... ylin, and calcitonin receptors
@en
P2093
David M Smith
Ian Marshall
Jan A Fischer
Remi Quirion
Roman Muff
Steven M Foord
Walter Born
P304
P3181
P356
10.1124/PR.54.2.233
P407
P577
2002-06-01T00:00:00Z